Research and experimental development on natural sciences and engineering
KLYV THERAPEUTICS AS
Revenue 2024
NOK 935,000
Operating profit
NOK 161,000
Equity
NOK 718,000
Incorporated
2023
Share capital
NOK 122,000
Organisation
Established
2023-08-30
Industry code
72.100
Legal form
AS
Group structure
Eier · 77.5%
SPRINGHEART HOLDING AS
Company
KLYV THERAPEUTICS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikling av legemidler.
Business address
Gaustadalléen 21, 0349 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.